Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
exenatide (byetta) (1 trial)
liraglutide (victoza) (1 trial)
Atherosclerosis (Phase 4)
Carotid Artery Diseases (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Insulin Resistance (Phase 4)
Trials (2 total)
Trial APIs (2 total)